Endoscopic Ultrasound Needles Market is projected to reach a valuation of US$ 223.5 Millon by 2027 | FMI

According to the latest study by Future Market Insights (FMI),  global endoscopic ultrasound needles market size is projected to increase from a valuation of US$ 180.2 Mn in 2022 to US$ 223.5 Mn by the end of 2027

The endoscopic ultrasound needles market is witnessing the advent of wide range of products including technological advancements in FNA and FNB for solid lesions. Endoscopic ultrasound have gained wide acceptance among surgeons as minimally invasive procedure along with EUS guided needles as the safe and minimally invasive method driving endoscopic ultrasound needles market growth.

Download Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-9247

Manufacturers in the endoscopic ultrasound needles market are focusing on new product launches for more precise diagnosis of tissues collected using needles. Gaining a greater share in the endoscopic ultrasound needles market with diverse portfolio is one of the key strategies of leading players.

As per the report, companies in the endoscopic ultrasound needles market are also focusing on collaborating for development and distribution of advanced endoscopic ultrasound needle products.

Key players in endoscopic ultrasound needles market are focusing on new product development in emerging regions including Latin America and Asia Pacific owing to the increasing prevalence of cancer and other chronic diseases.

Endoscopic Ultrasound-Guided Fine Needle Aspiration to Gain Popularity with Rise in Gastrointestinal Diseases

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-9247

According to the FMI report, Endoscopic Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) is likely to account for largest share in the endoscopic ultrasound needles market. EUS-FNA gaining popularity for the diagnosis of gastrointestinal diseases and peri-gastrointestinal lesions. The wide application of FNA has also accelerated the growth in the endoscopic ultrasound needles market.

With the growing demand for minimally invasive procedures, doctors and surgeons are using EUS combined with FNA to collect sample fluid and tissue from chest and abdomen for diagnosis. It has also emerged as an alternative to exploratory procedure.

Meanwhile, in recent years studies conducted on Endoscopic Ultrasound-Guided Fine Needle Biopsy (EUS-FNB) have shown some promising results. As per the FMI study on endoscopic ultrasound needles market, FNB is emerging as the novel tool in diagnosis by providing information on tissue architecture.

As per the study, ambulatory surgical centres will use endoscopic ultrasound needles on a large scale owing to the rise in number of these centres and increasing number of endoscopic ultrasound surgeries performed in ambulatory surgical centres.

Being the minimally invasive and non-surgical procedure that can be performed through colon or upper GI tract, ambulatory surgical centers are gaining traction in the endoscopic ultrasound needles market.

Moreover, endoscopic ultrasound is generally considered safe when performed at ambulatory surgical centres with expert healthcare team. Various healthcare organisations are building ambulatory surgical centres within the premises in the healthcare facility offering wide range of services with technological advancements to achieve economies of scale.

Increasing number of ambulatory surgical centers are offering safe, cost-effective services, especially for gastroenterology, thereby, driving the demand in the endoscopic ultrasound needles market.

Contact Sales for Further Assistance in Purchasing this Report https://www.futuremarketinsights.com/checkout/9247

Endoscopic Ultrasound Needles Industry Survey

Endoscopic Ultrasound Needles Market by Product:

  • Aspiration Needles (EUS-FNA)
  • Biopsy Needles (EUS-FNB)

Endoscopic Ultrasound Needles Market by Application:

  • Bronchial EUS Needles
  • Enteral EUS Needles

Endoscopic Ultrasound Needles Market by End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Endoscopic Ultrasound Needles Market by Region:

  • North America Endoscopic Ultrasound Needles Market
  • Latin America Endoscopic Ultrasound Needles Market
  • Europe Endoscopic Ultrasound Needles Market
  • East Asia Endoscopic Ultrasound Needles Market
  • South Asia & Pacific Endoscopic Ultrasound Needles Market
  • Middle East & Africa (MEA) Endoscopic Ultrasound Needles Market

More Trending Reports by Future Market Research :

Cardiac Biomarker Diagnostic Test Kits Market: is projected to expand at 5.1% CAGR over the forecast period, from 2022 to 2028.

Cardiac Assist Devices Market: is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Bn by 2031.

Digital Patient Monitoring Systems Market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 9-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Benign Prostatic Hyperplasia (BPH) Prostate Treatment Market is expected to rise at a steady CAGR of 4.7% from 2022 to 2028 | FMI

[252 Pages Report] The approximately US$ 25 Bn market for benign prostatic hyperplasia prostate treatment is likely to expand at 4.6% CAGR during 2018-2028, according to a recent research report of Future Market Insights (FMI). The report has envisaged steady growth prospects for the revenue of global benign prostatic hyperplasia prostate treatment market through 2028.

The World Population Prospects’ data (2017) projected that the number of individuals aged 60 years and above will double by 2050, and triple by 2100. With such a high pace estimated for the growth of population aged 60 years and above, it is more likely that the prevalence of aging related health conditions will also increase at a considerable pace in the years to come. A high prevalence rate of benign prostatic hyperplasia (BPH) in men, the demand for improved and more effective treatment options continues to increase at a high rate.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-16464

Alpha-blockers & Drugs for Lower UTIs Remain Pivotal in Benign Prostatic Hyperplasia Prostate Treatment

The drug treatment has been vital in treating benign prostatic hyperplasia conditions and lower UTIs, which has been attributed to widespread availability of drug-based benign prostatic hyperplasia prostate treatment. This factor, in particular, will play an instrumental role in driving the growth of the benign prostatic hyperplasia prostate treatment market during the forecast period. Drugs will remain the first choice of treatment for benign prostatic hyperplasia.

Benign prostatic hyperplasia increases the risk of other disorders as well. The most common disorder caused due to benign prostatic hyperplasia is lower UTI (urinary tract infection) for which, Alpha-blockers constitute the first line of treatment. However, other drugs are also available in the market, which offer relief from the benign prostatic hyperplasia symptoms. Other drugs include alpha reductase inhibitors, phosphodiesterase-5 (PDE-5) inhibitors, muscarinic receptor antagonists, and combination drugs.

Key Players:

  • Pfizer, Inc.,
  • Valeant Pharmaceuticals Inc.,
  • Novartis AG,
  • Bayer AG,
  • Sanofi S.A.,
  • GlaxoSmithKline plc.,
  • Bristol-Myers Squibb and Company,
  • Teva Pharmaceutical Industries Ltd,
  • Mylan N.V.,
  • Merck & Co.,
  • Cardinal Health Inc., and
  • Eli Lilly and Company among others.

Additional Questions Answered

Additional questions addressed in this benign prostatic hyperplasia prostate treatment market report are:

  • What is the revenue potential of the benign prostatic hyperplasia prostate treatment market across North America and Europe?
  • Who are the key players and what are their product portfolios in the benign prostatic hyperplasia prostate treatment market?
  • What are the major challenges impacting the growth of the benign prostatic hyperplasia prostate treatment market?
  • How is the involvement from key regulatory bodies shaping the growth of the benign prostatic hyperplasia prostate treatment market?

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1664

Demand for Benign Prostatic Hyperplasia Prostate Treatment Higher in Developed Regions, Patient Pool Expanding Steadily in Developing Markets

Owing to significantly growing prevalence of benign prostatic hyperplasia in North American men, benign prostatic hyperplasia prostate treatment market is expected to witness strong growth within the region, followed by Europe.

Extensive availability of benign prostatic hyperplasia prostate treatments, increasing clinical trials, improving R&D scenario, higher healthcare spending, and favorable government initiatives will continue to assist the growth of the benign prostatic hyperplasia prostate treatment market in developed regions.

On the other side, Asia Pacific’s benign prostatic hyperplasia prostate treatment market is foreseen to witness significant growth, owing to steadily expanding patient pool due in the region.

UroLift System to Revolutionize the Competitive Landscape of Benign Prostatic Hyperplasia Prostate Treatment Market

Teleflex Incorporated’s NeoTract recently launched UroLift® System as a highly effective, least invasive option for benign prostatic hyperplasia prostate treatment. The UroLift® System is permanently implanted via a transurethral outpatient procedure and predominantly relieves prostate obstruction, which is one of the primary symptoms of benign prostatic hyperplasia. The company has also declared insurance coverage for UroLift® System. While the coverage is being provided by Humana, it is most likely to improve awareness about increasing availability and broadening access of minimally invasive treatment methods in urological conditions such as benign prostatic hyperplasia. This in turn will encourage adoption of UroLift® System among patients seeking effective benign prostatic hyperplasia prostate treatment.

A majority of patients with enlarged prostate continue to perceive medication and surgery as the only available treatment alternatives. However, an increasing number of physician recommendations is advocating the use of The UroLift® System as it eliminates side effects associated with other conventional options of benign prostatic hyperplasia prostate treatment.

For more insights on the overall performance of global benign prostatic hyperplasia prostate treatment market through 2028, write to press@futuremarketinsights.com

Key Segment

Based on treatment type

  • alpha-blockers
  • alpha reductase inhibitors
  • phosphodiesterase-5 (PDE-5) Inhibitors
  • muscarinic receptor antagonist
  • combination drugs

Based on distribution channel

  • institutional sales
  • retail sales
  • online pharmacies

Explore Other Reports Links From Healthcare Market

Women Digital Health Solutions Market is estimated at US$ 2.3 Bn in 2022 and is projected to reach a valuation of US$ 20.1 Bn by 2032, expanding at a CAGR of 24.2% through the forecast period of 2022-2032

Zirconia Based Dental Ceramics Market is expected to be the highest revenue generating category, projected to register an absolute dollar opportunity of US$222 Mn during 2022 – 2032

Hard Gelatin Capsules Market is set to display a substantial growth at a CAGR of 6.4% from 2022 to 2032

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Clinical Decision Support Systems Market | Cerner, Epic, MEDITECH, Wolters Kluwer Health | By 2033

The projection term is expected to see a CAGR of 10.4% for the global Clinical Decision Support Systems Market In 2023, the market for clinical decision support systems is expected to be worth US$5.46 billion. By 2033, it is expected that the market for clinical decision support systems would have grown to a high of US$ 14.69 Bn.

The global clinical decision support systems market is likely to reach a valuation of US$ 2.2 Billion in 2022. However, Government recognition and initiatives to encourage the adoption of CDSS and EHR systems are estimated to further increase the demand for clinical decision support market is projected to grow at a robust CAGR of 8.2% between 2022 and 2032, totaling around US$ 4.9 Billion by the end of 2032.

Sample of Research Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15205

The adoption of clinical decision support in the healthcare industry and surging investments in R&D, and innovations in clinical decision support systems increase the demand for the market. Leading clinical decision support system manufacturers are increasingly focusing on introducing novel compact and advanced clinical decision support systems this in turn is anticipated to foster the market growth in the near future.

Also, the growing risk of data privacy and the lack of technically qualified and skilled staff to implement the CDSS and resolve related issues are some of the prominent factors anticipated to hinder the market’s growth during the forecast period.

Key Takeaways:

  • By product, the integrated CDSS segment is expected to record a 7.7% CAGR by 2032
  • By delivery mode, the on-premises segment to expand at a 7.7% growth rate during the forecast period
  • The U.S market to garner US$ 1.5 Billion and record a 7.7% CAGR from 2022-2032
  • Market in China to procure US$ 360 Million, expanding at a 7.7% growth rate during the assessment period

Request for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-15205

“Rising technological advancements, and rising prevalence of chronic diseases, high investments in R&D, and innovations in clinical decision support system are expected to fuel the demand of clinical decision support market over the forecast period,” says an FMI analyst.

Competitive Landscape

Eminent players of the global clinical decision support market include Cerner, Epic, MEDITECH, Wolters Kluwer Health, and Zynx Health among others. Recent key developments among players include:

  • In March 2022 — MEDITECH and Google Health announced collaboration on an integrated solution within MEDITECH’s Expanse platform to help clinicians provide the best care through quick and easy access to information from multiple sources with a true longitudinal view of a patient’s health history.
  • In October 2021- Cerner announces the launch of a new operating unit, Cerner Enviza, that offers data-driven solutions and research services to help bring clarity to multi-dimensional data through real-world evidence and insights. The combined expertise of the Cerner and Kantar Health teams is expected to help accelerate the discovery, development and deployment of therapies and advance clinical research and the life sciences industry to improve everyday health.
  • In February 2021— Zynx Health, has been ranked 1 in KLAS Research’s 2022 Best in KLAS Awards in the category of Clinical Decision Support – Care Plans and Order Sets. Zynx Health received near-perfect scores across the grading criteria (Culture, Loyalty, Operations, Product, Relationship, Value) used to assess Best in KLAS status. The award marks Zynx Health’s seventh Best in KLAS designation.

Speak to our Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-15205

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global clinical decision support market presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Product (Integrated CDSS, Standalone CDSS) by Delivery Mode (On-premises, Cloud-based) by Model (Knowledge-based, Non-knowledge based) by Type (Therapeutics, Diagnosis) by Component (Service, Software, Hardware) by Application (Advance CDSS, Conventional CDSS) by Level of Interactivity (Active CDSS, Passive CDSS) by Setting (In-patient, Ambulatory Care Settings) and Region (North America, Latin America Europe, APAC, and Middle East & Africa,)

Key Segments Of Clinical Decision Support Industry Survey

Clinical Decision Support Market by Product:

  • Integrated CDSS
  • Standalone CDSS

Clinical Decision Support Market by Delivery Mode:

  • On-premises Clinical Decision Support
  • Cloud-based Clinical Decision Support

Clinical Decision Support Market by Model:

  • Knowledge-based Clinical Decision Support
  • Non-knowledge based Clinical Decision Support

Clinical Decision Support Market by Type:

  • Clinical Decision Support for Therapeutics
  • Clinical Decision Support fort Diagnosis

Clinical Decision Support Market by Component:

  • Clinical Decision Support Service
  • Clinical Decision Support Software
  • Clinical Decision Support Hardware

Clinical Decision Support Market by Application:

  • Advance CDSS
  • Conventional CDSS

Clinical Decision Support Market by Level of Interactivity:

  • Active CDSS
  • Passive CDSS

Clinical Decision Support Market by Setting:

  • In-patient Clinical Decision Support
  • Clinical Decision Support in Ambulatory Care Settings

Top Related Reports Healthcare Market Insights

Peptide Receptor Radionuclide Therapy (PRRT) Market

Non-invasive Brain Stimulation System Market

Non-Hyaluronic Acid Dermal Filler Market

Oncology Blood Testing Market

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com

Browse All Reports: https://www.futuremarketinsights.com/reports

LinkedIn| Twitter| Blogs

Plant Derived Proteins Market is projected to reach US$ 105 Mn by the end of 2022 | FMI

[273 Pages Report] Production and commercialization of biopharmaceutical proteins with higher therapeutic efficacy have formed a progressive landscape that continues to push the growth of plant derived proteins market. A new Future Market Insights (FMI) report forecasts that the plant derived proteins market will experience a major upturn towards 2029, reaching a value of around US$ 185 Mn. Production of three main therapeutic protein classes, including antibodies, vaccines, and replacement proteins such as albumin, insulin, growth factors, and cytokines will remain industry’s prime focus area.

Plant derived proteins are recognized as natural and environmentally-sustainable than microbial and mammalian cells. Owing to these benefits, there has been an increasing demand for such proteins from biopharmaceutical companies, as raw materials for therapeutic drug production, creating an absolute opportunity for growth of the plant derived proteins market.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-11038

Attribute Details
Plant Derived Proteins Market Estimated Size in 2022 US$ 105 Mn
Plant Derived Proteins Market Projected Size in 2029 US$ 184.3 Mn
Plant Derived Proteins Market Historical CAGR (2014-2021) 7.6%
Plant Derived Proteins Market Value-based CAGR (2022-2029) 8.4%

Key Takeaways of Plant Derived Proteins Market Study

  • The production of therapeutic proteins for disease treatment will gain traction, contributing more than 70% to global market revenues in 2029.
  • Owing to low setup cost, transient plant expression systems (carrot or tobacco) remains preferred among protein manufacturers.
  • Regenerative medicine-therapeutic agents continue to be the leading application area, on the back of their relatively cheap price point.
  • Biopharmaceutical companies represent the leading consumer industry of plant derived proteins, with over 50% share in market throughout the forecast period.
  • North America continues to lead, whereas East Asia holds the promise of lucrative opportunities, owing to several healthcare programs.

Acquisition Key Strategy Followed by Leading Market Players

Leading manufacturers in the plant derived proteins market are focusing on regional acquisition strategy to enhance their product portfolio and expand their regional presence.  For instance, in 2017, Denka buys pharming pioneer Icon Genetics, which is a leading manufacturers of therapeutic proteins in plants. In 2014, Kentucky BioProcessing, Inc. was acquired by Reynolds American Inc., which is a wholly owned subsidiary of tobacco manufacturing company British American Tobacco plc.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-11038

Interested in more insights on the build-up of plant derived proteins market?

Plant derived proteins market, a new study from future market insights, opines on the production of plant derived proteins from 2014 – 2018 and presents demand projections from 2019 – 2029 on the basis of; plant type (tobacco, carrot, rice, barley and others), protein type (industrial proteins & enzymes, therapeutic proteins cell culture functional proteins and others), application (regenerative medicine-therapeutic agents, regenerative medicine-functional material, cell culture application and others), platform (in-vitro culture system, whole plants and others) and end user (biopharmaceutical companies, academic & research institutes, contract research organization (CROS), contract manufacturing organization (CMOS)) across seven prominent regions.

The global plant derived proteins market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Plant

  • Tobacco
  • Rice
  • Carrot
  • Barley
  • Others

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-11038

Protein

  • Industrial Proteins& Enzymes
  • Therapeutic Proteins
  • Blood Proteins
  • Cell Culture Functional Proteins
  • Others

Platform

  • In-vitro Cell Culture Systems
  • Whole Plants
  • Others

Application

  • Regenerative Medicine-Therapeutic Agents
  • Regenerative Medicine-Functional Material
  • Cell Culture Application
  • Others

End User

  • Biopharmaceutical Companies
  • Academic & Research Institutes
  • Contract Research Organization (CROs)
  • Contract Manufacturing Organization (CMOs)

Have a Look at Related Research Reports of Healthcare Domain

AI-based Clinical Trials Solution Provider Market  is estimated at US$ 1.7 Bn in 2022 and is projected to reach a valuation of US$ 14.2 Bn by 2032, expanding at a CAGR of 23.2% through the forecast period of 2022-2032

COVID-19 Saliva Sampling Test Potential Market analysis report by Future Market Insights shows that global sales of COVID-19 Saliva Sampling Test Potential Market in 2021 were held at US$ 3.1 Bn

IV Therapy and Vein Access Devices Market is likely to propel to US$ 44.4 Billion by 2032. The trade is projected at a 5.6% CAGR during the forecast period

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Lung Cancer Surgery Market is expected to reach US$ 1.98 Billon by 2029

[252 Pages Report] Over 2 million new cases of lung cancer were registered globally by the end of 2021, as reported by the American Cancer Society, Inc. The global lung cancer surgery landscape currently represents a US$ 1 Bn market and will expand at a strong CAGR during the period of projection, 2022 – 2029. A new Future Market Insights (FMI) report states that the use of techniques that are minimally invasive, video assisted, and robot assisted is growing, which is shaping the future of lung cancer surgery market.

Robotic thoracic surgery would remain highly preferred over traditional surgical techniques, as it offers higher magnification, more precision, and eliminate the need for large-incision operations. Development of new surgical robots may cut down the cost of devices and increase shift towards robotic lung cancer surgery. Introduction of new imaging techniques for enhancing visualization, angled lenses for enhanced accessibility, and end staplers will continue to enhance the video-assisted lung cancer surgery procedure.

Intuitive Surgical is the sole player in robotic lung cancer surgery market with its DaVinci system. Medtronic and Johnson & Johnson are developing surgical robots and are challenging the monopoly of Intuitive Surgical in lung cancer surgery market.

Request Sample Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-396

Key Takeaways – Lung Cancer Surgery Market Study

  • Introduction of powered and tissue-specific endoscopic stapling technology provides significant benefits to reduce cost, resource usage, improve clinical outcome compared to manual staplers.
    • In September 2022, Johnson & Johnson launched ECHELON CIRCULAR™ Powered Stapler for thoracic, colorectal, and gastric surgery.
    • In March 2016, Intuitive Surgical Inc. got U.S. FDA approval for its da Vinci Xi Endowrist Stapler 30 (30 mm) instruments and reloads.
  • Key market players are focusing on the development of new robot-assisted thoracic surgery system. Partnerships & collaborations with best in class surgical device and visualization technology developers are the strategic focus of manufacturers. For instance,
    • Medtronic partnered with Karl Stroz, a best in class endoscopic imaging devices manufacturer. In June 2022, Medtronic announced its upcoming robotic-assisted surgical platform including three-dimensional vision systems from Karl Stroz.
  • East Asia is expected to be the prominent region in the lung cancer surgery market during the forecast year. This is attributed to high prevalence of lung cancer in China & Japan increasing the demand for lung cancer surgery. According to the International Agency for Research on Cancer, from overall cancer patients in China and Japan, around 18.1% and 16.8% patients respectively were having lung cancer.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-396

Development in robotic thoracic surgery platforms and innovation in tissue-specific endoscopic stapling and vessel sealing techniques to reduce endoleak complications will further broaden the growth prospects of the lung cancer surgery market.

Product Portfolio Expansion to Increase Global Footprint

Manufacturers are adopting product portfolio expansion strategy to increase their footprint in the global lung cancer surgery market. Market players such as Pentax Medical, Olympus, Johnson & Johnson, Intuitive Surgical Inc. are continuously focusing on new product launches and regulatory approvals. For instance,

  • In July 2016, PENTAX Medical launched new DEFINA high-definition pulmonology endoscopy system for crystal clear imaging during surgical procedures.
  • In April 2018, Intuitive Surgical Inc. received U.S. FDA clearance for da Vinci Vessel Sealer Extend single-use, the fully wristed bipolar electrosurgical instrument for lung cancer surgery procedures such lobectomy, segmentectomy, and wedge resection.

Request Discount @ https://www.futuremarketinsights.com/request-discount/rep-gb-396

Lung Cancer Surgery Market by Category By Product:

  • Thoracoscopes
  • Mediastinoscopes
  • Bronchoscopes
  • Robotic-Assisted Thoracic Surgery Systems
  • Surgical Staplers
  • Surgical Energy Instruments
    • Advanced Energy Instruments
      • Advanced Bipolar Instruments
      • Ultrasonic Instruments
    • Basic Energy Instruments
      • Bipolar Instruments
      • Monopolar Instruments

By Application:

  • Lobectomy
  • Segmentectomy
  • Wedge Resection
  • Pneumonectomy

By End-User:

  • Hospitals
  • Ambulatory Surgical Centers

Explore FMI’s Extensive ongoing Coverage on Healthcare Domain

Lab Accessories Market is anticipated to register a CAGR of 6.8% during the period of 2022-2032. The market is anticipated to reach US$ 1.1 Billion in 2032, from US$ 585.0 Million in 2022

Nuclear Medicine Equipment Market is expected to have a steady CAGR of 4.1% during the period 2022-2032

Contraceptives Market is expected to reach a valuation of US$ 18 Bn in 2022. Demand for contraceptive drugs and devices is slated to surge at a 5.5% CAGR, with the total market size reaching US$ 30.8 Bn by 2032

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Tissue Engineered Skin Substitute Market is expected to reach US$ 4.13 Bn by 2029 | Future Market Insights

[248 Pages Report] Rapid expansion of wound management space has argued well for the growth in demand for tissue engineered skin substitutes. The global tissue engineered skin substitute market is projected for a robust 9.6% CAGR during 2022 – 2029, predominantly driven by high applicability in diabetic foot ulcers and other chronic wounds.

With advent of tissue engineering and improved ability to combine advanced manufacturing technologies with biomaterials and cell culture systems, more biomimetic tissue constructs have been emerged. Technological advancements are leading to production of advanced tissue engineered skin substitutes. 3D bioprinting and biotextile are emerging as popular biofabrication strategies for creating bioengineered skin substitutes. A team of researchers in the U.S. recently discovered a technology for complete 3D printing of the living skin along with blood vessels. Emergence of such revolutionary fabrication technologies will create a massive opportunity in the global market.

Despite breakthrough innovations assisting the growth of market, certain limitations are still there. The inability of tissue engineered skin substitutes to produce skin appendages such as hair follicles, sebaceous glands, and nails continues to remain among the most concerning challenges facing R&D teams

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-781

Key Players : 

  • Smith & Nephew plc.
  • Acelity L.P. Inc.
  • Mölnlycke Health Care
  • Integra Life Sciences
  • Allergan plc
  • Regenicin
  • Organogenesis Inc.
  • MiMedx
  • LifeNet Health
  • Kerecis
  • Medline Industries, Inc.

Key Takeaways – Tissue Engineered Skin Substitute Market Study

  • With increasing researches in tissue engineering, the demand for   biologic skin substitute is expected to increase in the forecast period. For instance, a team of engineers at the California Institute of Technology (Caltech) and ETH Zurich have developed an artificial skin made from pectin, a naturally occurring long-chain molecule present in plant cell walls allowing the construction of natural and new dermis.
  • Increasing prevalence of diabetes and chronic wounds is boosting the demand for tissue engineered skin substitutes.
  • The demand for tissue engineered skin substitutes in emerging economies such as China and India is expected to increase owing to increasing incidence of diabetic foot ulcers, venous leg ulcers, and pressure ulcers.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-781

tissue engineered skin substitute market

Leading Manufacturers Setting the Pace for Product Innovations

The tissue engineered skin substitute market is a consolidated market. The tier 1 companies in the tissue engineered skin substitute market such as Allergan Plc., Mimedex Group Inc., Integra LifeSciences Corp. and Integra LifeSciences Corp. are expected to hold more than half of the total revenue generated by tissue engineered skin substitutes. The key players in the market are reshaping their current product portfolio by focusing on the introduction of new and advanced technologies and innovating new products.

Seeking More Insights?

Tissue engineered skin substitute market, a new study from Future Market Insights, opines on the evolution of tissue engineered substitute market from 2014 – 2021 and presents demand projections from 2022 – 2029 on the basis of; product (acellular skin substitute, biologic skin substitute, cellular skin substitute and synthetic substitute), material (synthetic and natural), application (chronic wound, acute wound and other applications such as breast reconstruction etc.) and end user (hospital, specialty clinics, ambulatory surgical centres and research laboratories) across seven prominent regions.

For in-depth competitive analysis, Buy Now – https://www.futuremarketinsights.com/checkout/781

Tissue Engineered Skin Substitute Market by Category By Product:

  • Acellular Skin Substitutes
    • Acellular skin substitutes based on Amniotic Membrane
    • Other Acellular skin substitutes
  • Biologic Skin Substitute
    • Allograft
    • Xenograft
  • Cellular Skin Substitutes
    • Cellular skin substitute based on amniotic membrane
    • Other cellular skin substitutes
  • Synthetic Skin Substitutes

By Material:

  • Synthetic
  • Natural

By Application:

  • Chronic Wounds
    • Venous leg Ulcers
    • Diabetic Foot Ulcer
    • Pressure Ulcers
  • Acute Wounds
    • Traumatic Wounds
    • Burn Cases
  • Other Applications

By End User:

  • Hospital
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Research Laboratory

More Trending Reports by Future Market Research: 

Cardiac Assist Devices Market: is poised to expand at 5.29% CAGR, reaching US$ 2,062.7 Bn by 2031.

Digital Patient Monitoring Systems Market is estimated at US$ 96.4 Bn in 2022 and is projected to reach a valuation of US$ 470 Bn by 2032, expanding at a CAGR of 17.2% through the forecast period of 2022-2032

Women Digital Health Solutions Market is estimated at US$ 2.3 Bn in 2022 and is projected to reach a valuation of US$ 20.1 Bn by 2032, expanding at a CAGR of 24.2% through the forecast period of 2022-2032

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Transcutaneous Monitors Market is set to experience a significant growth of 4.3% CAGR from 2022 to 2029 | FMI

[207 Pages Report] Due to the technological advancement in multichannel monitors, demand for multipara, multichannel transcutaneous monitors is increasing day by day. Despite channel limitations and lack of technological advancements, single channel transcutaneous monitors are likely to garner significant traction in developing countries, in the view of relatively large difference in price as compared to multi-channel transcutaneous monitors.

Stakeholders in the transcutaneous monitors market are showing a palpable duality in their approach – in addition to increasing the sales of multi-channel monitors in high income countries, manufacturers are likely to tap into opportunities in price sensitive countries by offering low-cost yet significantly efficient products, according to the FMI analyst. 

Data Points Market Insights
Market Value 2021 US$ 385.1 Mn
Market Value 2022 US$ 401.8 Mn
Market Value 2029 US$ 540.1 Mn
CAGR 2022-2029 4.3%
Market Share of Top 5 Countries 56.8%

Multichannel Transcutaneous Monitors to Show Higher Opportunities for New Players

In recent years, the transcutaneous monitors market has been witnessing significant growth, on the back of wide availability of advanced and multi-channel transcutaneous monitors for patient monitoring. The multi-channel transcutaneous monitors involves simultaneous measurement of the ECG, brain functioning, blood gas measurement, and hemoglobin level. Due to rising demand for technologically advanced medical devices, healthcare professionals are giving more priority to buy multichannel transcutaneous monitors. As compared to single-channel transcutaneous monitors, multichannel transcutaneous monitors are fast and provide accurate results. Companies, in the transcutaneous monitors market, are launching products with longer battery life and benchtop portability. Such factors are thus expected to enhance the growth of the transcutaneous monitors market in coming years.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-4980

Market Players to Make Two-Fold Investments in APAC  

The APAC region has more demand for the transcutaneous monitors, due to growing number of hospitals and rising regional government initiatives towards public healthcare program. In the APAC region, South Asian countries including India have more number of hospitals. The mounting number of hospitals is expected to create additional demand for transcutaneous monitors in the future. In addition, growing number of local market players operating in countries such as China is expected to intensify the competition in the transcutaneous monitors market in the coming years.

The transcutaneous monitors market is expected to continue sustaining high demand for multichannel transcutaneous monitors, finds the report. As per FMI’s study, significant sales opportunities for the transcutaneous monitors market players are expected in the APAC & Latin America, owing to robust development in healthcare sectors along with favorable government policies for reduced cost of treatment. Also, there are opportunities in the APAC transcutaneous monitors market for new players, including tax exemption for the first three years.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-4980

FMI completed a deep study on transcutaneous monitors by keeping the breadline view in mind about the market CAGR and value share analysis. During the transcutaneous monitors market study, we also studied the top manufacturers’ differential strategies & supply chain parameters. The giant players such as Masimo & Danaher Corporation are focusing on enhancing their product portfolios through the launch of new technology in the transcutaneous monitors market and patented technology in the patient monitoring field. These developmental activities implemented by the top players will remain key to gaining distinct competitive edge in the market.

According to the report, the manufacturer are targeted towards innovations in the continuous patient monitoring field. Some innovations include the overnight patient transcutaneous gas monitors and auto-sleep mode patient monitors. They are the latest monitors with longer battery life and wireless capacity. Some monitors can further work on the smartphone-based application which can help monitor remote-based patients. For the neonate’s care, companies are launching the transcutaneous monitors with gold plated sensors compatibility and better accuracy.

Key Market Segments Covered in Transcutaneous monitors Industry Research

By Channel Type

  • Single Channel
  • Multichannel

By End User                                   

  • Hospitals
  • Ambulatory Surgical Centers
  • Diagnostic Laboratories
  • Home Care Settings

Explore Wide-ranging Coverage of FMI’s Healthcare Landscape

Immunoassay Market Size : The global immunoassay market is expected to be worth USD 45.78 billion by 2032, growing at a CAGR of 5% from its current value of USD 29.51 billion in 2022.

3D Printed Medical Implants Market Share : The global demand for 3D printed medical implants is expected to rise at a healthy CAGR of 12.5% to be valued at US$ 2,494.5 million by 2032.

Humanized Mouse Model Market Trends : The global humanized mouse model market is expected to be valued at US$ 92.5 Million in 2022. Throughout the decade spanning 2022-2032

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Spinal Osteosynthesis Units Market is projected to grow at a steady CAGR of 4.8% From 2022 – 2032

[250 Pages Report] Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Spinal Osteosynthesis Units Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period.

Impact of COVID-19 on the Healthcare Industry

The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9583

The team of analysts at Future Business Insights are focussing on research and market study to produce different Spinal Osteosynthesis Units Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Spinal Osteosynthesis Units Market.

Key Players 

Some of the key players present in global spinal osteosynthesis units market are Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, NuVasive, B. Braun, Globus Medical, Alphatec, Orthofix, Xtant Medical, Wego, MicroPort, RTI Surgical, Integra LifeSciences, Ulrich Medical and others.

Segmentation 

The global Spinal Osteosynthesis Units market is segmented by product type, surgical approach, patient type, end user, and regions:

Spinal Osteosynthesis Units Segmentation by Product Type

  • Thoracolumbar Osteosynthesis Unit
  • Lumbar Spinal Osteosynthesis Unit
  • Lumbosacral Osteosynthesis Unit
  • Thoracolumbosacral Osteosynthesis Unit
  • Occipitocervicothoracic Osteosynthesis Unit
  • Cervical Thoracic Lumbo Sacral Osteosynthesis Unit

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-9583

Spinal Osteosynthesis Units Segmentation by Surgical Approach

  • Posterior
  • Anterior
  • Lateral

Spinal Osteosynthesis Units Segmentation by Patient Type

  • Adult
  • Pediatric

Spinal Osteosynthesis Units Segmentation by End User

  • Hospital
  • Specialty Clinic
  • Others

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-9583

Queries Solved

What is the size of the overall Spinal Osteosynthesis Units Market in the Healthcare Industry and its segments?

What are the key segments and sub-segments in the market?

What are the key drivers, restraints, opportunities, and challenges of the Spinal Osteosynthesis Units Market in the Healthcare Industry, and how they are expected to impact the market?

What are the attractive investment opportunities within the Spinal Osteosynthesis Units Market in the Healthcare Industry?

What is the Spinal Osteosynthesis Units Market in the Healthcare Industry size at the regional and country-level?

What are the key market players focusing on?

What are the strategies for growth adopted by the key players in Spinal Osteosynthesis Units Market in the Healthcare Industry?

What are the recent trends in Spinal Osteosynthesis Units Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)?

What are the challenges to the Spinal Osteosynthesis Units Market in the growth of the Healthcare Industry?

What are the key market trends impacting the growth of the Spinal Osteosynthesis Units Market in the Healthcare Industry?

Reasons to buy the report

  • We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
  • Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
  • The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

More Trending Reports by Future Market Research :

Vision Screeners Market

Analgesics Market

Cellulite Treatment Market 

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Steroid-Free Nasal Sprays Market is expected to reach US$ 14.9 Billon by 2032 | FMI

[225 Pages Report] Steroid-free nasal sprays are medications that are directly delivered to nasal cavities with the avoidance of first-pass metabolism and also provide better bioavailability. It includes nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, and nasal cromolyn sodium sprays.

As per Future Market Insights’ latest industry analysis, the global steroid-free nasal sprays market was valued at over US$ 7.75 Bn in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period, pushing the market size to US$ 14.9 Bn by 2032.

Data Points Market Insights
Steroid-free Nasal Sprays Market Base Yea Value (2021) US$ 7.7 Bn
Estimated Market Size (2022) US$ 8.1 Bn
Projected Market Valuation (2032) US$ 14.9 Bn
Value-based CAGR (2022-2032) 6.3%
Share of Top 5 Countries 57.9%

There is a subsequent rise in the prevalence of allergic rhinitis worldwide due to several risk factors including urbanization and environmental pollutants. According to a recent study conducted in 2022, allergic rhinitis affects about 25% to 40% of the population worldwide. It also states that approximately 80% of allergic rhinitis symptoms develop before the age of 20.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15127

Recently, there has been an increasing emphasis on mental illnesses due to the significant rise in cases of major depressive disorders. Among these, depression is a common mental disorder. According to WHO, approximately 280 million people of all ages suffer from depression.

Due to rising adverse effects of depression, manufacturers in the steroid-free nasal sprays market are focusing on introducing products that can be used for the treatment of these disorders in the most effective manner.

Moreover, an increased number of regulatory approvals have been observed in the steroid-free nasal sprays market which is propelling the launch of innovative products. Therefore, manufacturers in the market are focusing on getting regulatory approvals to improve sales in the market.

“Rising availability of generic nasal sprays, along with increasing promotional activities by manufacturers at online channels will boost sales of steroid-free nasal sprays over the assessment period,” says an FMI analyst.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15127

Key Takeaways:

  • Based on product type, sales of nasal antihistamine sprays will increase at a 5.9% CAGR through 2032.
  • The aqueous by formulation segment dominated the steroid-free nasal sprays market with around 4% share in 2021.
  • In terms of distribution channels, demand in the institutional segment will grow at a 6% CAGR through 2032.
  • North America accounted for the highest share of 6% of the global steroid-free nasal sprays market share in 2021.

Competition Landscape

Prominent players operating in the global steroid-free nasal sprays market are focusing on the development, launch, and approval of innovative products to improve their product portfolios. For instance:

  • In February 2022, Glenmark Pharmaceuticals Limited along with SaNOtize Research & Development Corp. announced the launch of FabiSpray, the nitric oxide nasal spray for the treatment of COVID-19 in India.
  • In March 2021, Cipla Limited announced that it has received final approval from the FDA for its abbreviated new drug application (ANDA) for Sumatriptan Nasal Spray, 20 mg which is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex nasal spray.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the steroid-free nasal sprays market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032. The global steroid-free nasal sprays market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The steroid-free nasal sprays market is segmented into three parts based on the product (nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, nasal cromolyn sodium sprays, and others), formulation (aqueous, suspension, nonaqueous-based solution, hydroalcoholic, emulsions, and dry powder/micro particles) and distribution channel- (institutional sales {hospitals, specialty clinics, community clinics, public health agencies, and others}, retail sales {retail pharmacy, drug stores, mail order pharmacy}), across seven key regions of the world.

Key Players :

  • Janssen Pharmaceutical, Inc.
  • Astra Zeneca Plc.
  • Cipla Ltd.
  • Glenmark Pharmaceuticals
  • Glaxosmithkline Plc.
  • Novartis International AG
  • Procter & Gamble
  • Sanofi S.A. (Sanofi-aventis LLC.)
  • Boehringer Ingelheim GmbH
  • AdvaCare Pharma
  • Bayer AG (Bayer Consumer Health
  • Covis Pharma S.a.r.l.
  • Nipro Corporation (NIPRO JMI Pharma Ltd.)
  • Viatris Inc. (Meda Pharmaceuticals Inc.)
  • Perrigo Company plc
  • AptarGroup, Inc.
  • Berry Global, Inc.
  • URSATEC GmbH
  • Gerresheimer AG
  • Avantor, VWR International, LLC
  • Spectrum Laboratory Products, Inc.  (Spectrum Pharmacy Products)
  • SKS Bottle & Packaging, Inc.
  • Coster Tecnologie Speciali S.p.A

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15127

Steroid-Free Nasal Sprays Market by Category

By Product:

  • Nasal Antihistamine Sprays
  • Nasal Decongestant Sprays
  • Nasal Anticholinergic Sprays
  • Nasal Cromolyn Sodium Sprays
  • Others

By Formulation:

  • Aqueous
  • Suspension
  • Nonaqueous-Based Solution
  • Hydroalcoholic
  • Emulsions
  • Dry Powder/Micro Particles

By Distribution Channel:

  • Institutional Sales
    • Hospitals
    • Specialty Clinics
    • Community Clinics
    • Public Health Agencies
    • Others
  • Retail Sales
    • Retail Pharmacy
    • Drug Stores
    • Mail Order Pharmacy

More Trending Reports by Future Market Research :

Behavioural Health Market 

Nuclear Medicine Equipment Market

Enzyme Replacement Therapy Market

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Sterile Oncology Injectable Market Trends, Demand Growth Revenue Analysis Report to 2028

Injectable drug delivery is the mode of introduction of a drug directly into the bloodstream of a patient. Drugs are directly injected into the bloodstream of patients, owing to which they need to be sterile. Sterile injectable drugs are usually available in liquid form. Sterile injectable drugs are usually permit to transport directly into blood stream sometimes. The manufacturing of sterile injectable drugs is a complex process and recurs high initial investment and operating cost.

Major factor that is increasing the demand for sterile injectable is increasing number of cancer cases. According to the World Cancer Research Fund International (WCRFI), around 14.1 million cancer cases were accounted worldwide in 2012. As per the WCRFI, till 2035, the number is expected to reach 24 million. Small molecule monoclonal antibodies are used for cancer treatment therapy. Cancer therapies are the import engine of the growth of the sterile oncology injectable market.

Focus of the Manufacturers on Technologies, Materials and Robust Manufacturing Process

The supply of drugs is short in the U.S., with some shortage continuing for multiple years. The majority of these drugs are generic sterile injectable products. Companies are focusing on increase in supply of sterile oncology injectable. Manufactures are now focusing on superior technology and procurement of higher grade raw materials. Contract manufacturing organization can help to address drug shortage problem in North America and Europe. They adopt new technologies and rapidly transfer in sterile injectable manufacturing processes.

Dynamics of the Sterile Oncology Injectable Market

The global sterile oncology injectable market is projected witness significant growth over the forecast period due to rising prevalence of cancer globally. Increase in investment by drug manufactures in the development of sterile oncology injectable, short time frame for approval of new drug in cancer treatment are some of the key factor boosting demand for sterile oncology injectable market globally. Rapid FDA approvals of sterile oncology injectable along with shortened approval times for drug development in cancer care is helping manufacturers to accelerate drug supplies.

These factors are eventually boosting the growth of the global sterile oncology injectable market. However, stringent rules and regulations in manufacture of sterile oncology injectable and high quality and care required in manufacturing, challenges in storage, packaging and distribution of oncological sterile injectable are likely to hamper the growth of sterile oncology injectable market. Also, sterile drugs require complex equipment for manufacturing.

Request a Sample:

https://www.futuremarketinsights.com/reports/sample/rep-gb-6604

Market Expansion Due to Agreements and Partnerships

Sterile oncology injectable manufacturers are focusing on partnership and geographical expansion in different countries to establish facilities in various regions. Pfizer has expanded its oncology portfolio with acquisition of Hospira. Hospira has a broad sterile injectable product line, which includes acute care and oncology injectable. Baxter also acquired India-based injectable firm Claris Injectable Limited and expanded its portfolio in anti-infective, analgesics and critical care and oncology injectable.

Regional Market Outlook

North America will continue to dominate the global market due to the availability of advanced technologies and more number of clinical trial, surge in demand for innovative medical technology in the U.S. According to the National Institute of Cancer in 2016, around 1,685,210 new cancer cases are likely to be diagnosed in the U.S. Europe is expected to hold second large market share in global sterile oncology injectable market due to growing prevalence of chronic diseases. Competition from low-cost pharmaceutical manufacturing countries such as India and China has led to discontinuation of many products.

Asia Pacific is expected to exhibit attractive market share owing to increase in health awareness and demand for advanced medical technology in oncology treatment and increasing investments on low-cost pharmaceutical manufacturing.

Competition Outlook

Examples of some of the key players identified in the global sterile oncology injectable market are Eli Lilly & Company, Biocon Ltd, Baxter International Inc., Hikma Pharmaceuticals PLC, Mylan N.V., Sandoz International GmbH, Teva Pharmaceuticals Industries Ltd, and Pfizer Inc., among others. Sterile oncology injectable are used for cancer treatment and therapies.

Recent M&A activities have fueled the growth prospect for sterile oncology injectable. Recent deal of US$ 17 Billion between Pfizer & Hospira provides platform for growth for Pfizer’s Global Established Pharmaceutical (GEP) business. Hospira’s generic sterile injectable products, including acute care and oncology injectable have provided boost to Pfizer’s sterile injectable offerings in oncology market. However, preference of large molecules offers a global opportunity to its manufacturers, as these are the common molecules recently used globally for oncology application.

Ask for Customization:

https://www.futuremarketinsights.com/customization-available/rep-gb-6604

Key Data Points Covered in Report

The report covers exhaustive analysis on:

  • Sterile Oncology Injectable Market by molecule type, distribution channel, indication and region
  • Regional level market analysis of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding China & Japan, China, Japan, Middle East & Africa by molecule type, distribution channel, indication segments and country
  • Sterile Oncology Injectable Market Dynamics & Opportunity Assessment
  • Historical Actual Market Size, 2013 – 2017
  • Sterile Oncology Injectable Market Size & Forecast 2018-2028
  • Sterile Oncology Injectable Market Current Trends/Issues/Challenges
  • Competition & Companies involved

Research Methodology

The market sizing of sterile oncology injectable will be done by adoption data triangulation approach. Demand side approach will be followed to assess the actual market size of sterile oncology injectable. Secondary research will be performed at the initial phase to identify the Age specific disease epidemiology, diagnosis rate and treatment pattern, as per disease indications. Each piece of information will be eventually analyzed during the entire research project, which helps build a strong base for the primary research information.

Primary research participants include demand-side users such as key opinion leaders, physicians, surgeons, nursing managers, clinical specialists who provide valuable insights on trends and clinical application of the drugs, key treatment patterns, adoption rate, and compliance rate. Quantitative and qualitative assessment of basic factors driving demand, economic factors/cycles and growth rates and strategies utilized by key players in the market is analyzed in detail while forecasting, in order to project Year-on-Year growth rates. These Y-o-Y growth projections are checked and aligned as per industry/product lifecycle and further utilized to develop market numbers at a holistic level.

Get In Touch With Our Team For 20% Flat Discount:

https://www.futuremarketinsights.com/reports/brochure/rep-gb-6604

Market Segmentation

By Molecule Type

  • Small Molecule
  • Large Molecule

By Product type

  • Chemotherapy
  • Monoclonal Antibodies
  • Cytokines
  • Peptides Hormones

By Indication

  • Ovarian Cancer
  • Breast Cancer
  • Lung Cancer
  • Pancreatic Cancer
  • Other

By Distribution Channel

  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific Excluding China & Japan
  • China
  • Japan
  • Middle East & Africa

ABOUT FUTURE MARKET INSIGHTS, INC.

Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.

Now avail flexible Research Subscriptions, and access Research multi-format through downloadable databooks, infographics, charts, interactive playbook for data visualization and full reports through MarketNgage, the market intelligence engine from Future Market Insights. Sign Up for a 7 day free trial!

Contact:

Future Market Insights, Inc.

Christiana Corporate, 200 Continental Drive,

Suite 401, Newark, Delaware – 19713, USA

T: +1-845-579-5705

Enquiries: sales@futuremarketinsights.com

LinkedIn| Twitter| Blogs